You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hormone naïve

Showing 1 - 25 of 6,908
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostatic Tumors Trial in San Francisco (Pembrolizumab, SD-101, Leuprolide acetate)

Active, not recruiting
  • Prostatic Neoplasms
  • San Francisco, California
    University of California San Francisco
Sep 20, 2022

Prostate Cancer Metastatic, Prostate Cancer Trial in Houston (Abiraterone Acetate, Prednisone)

Recruiting
  • Prostate Cancer Metastatic
  • Prostate Cancer
  • Houston, Texas
  • +2 more
Oct 7, 2022

Metastatic Prostate Cancer Trial in Spain (Enzalutamide, Talazoparib)

Recruiting
  • Metastatic Prostate Cancer
  • Badalona, Spain
  • +8 more
Jan 18, 2023

Metastatic Hormone Naive Prostate Cancer Trial in Australia (177Lu-PSMA-617, Docetaxel)

Recruiting
  • Metastatic Hormone Naive Prostate Cancer
  • Sydney, New South Wales, Australia
  • +4 more
Nov 4, 2022

Prostate Cancer Metastatic to Bone Trial in Salt Lake City (Radium Ra 223 Dichloride, Radiation)

Active, not recruiting
  • Prostate Cancer Metastatic to Bone
  • Radium Ra 223 Dichloride
  • Radiation
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Sep 20, 2021

Metastatic Prostate Carcinoma, Prostate Adenocarcinoma, Prostate Carcinoma Metastatic in the Bone Trial in Houston (Abiraterone

Active, not recruiting
  • Metastatic Prostate Carcinoma
  • +5 more
  • Abiraterone Acetate
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 26, 2022

Prostate Cancer Trial in Worldwide (ODM-201, ADT)

Active, not recruiting
  • Prostate Cancer
  • Brussels, Belgium
  • +11 more
Jun 9, 2022

GHD Trial in Fort Worth (GenSci004, Genotropin)

Not yet recruiting
  • GHD
  • Fort Worth, Texas
    Cook Childrens
Aug 24, 2023

Growth Hormone Deficiency Trial in Santiago (LUM-201)

Recruiting
  • Growth Hormone Deficiency
  • Santiago, Chile
    Institute of Maternal and Child Research, University of Chile
Jul 12, 2022

Hormone-Resistant Prostate Cancer, Metastatic Prostate Carcinoma, Prostate Carcinoma Metastatic in the Bone Trial in United

Recruiting
  • Hormone-Resistant Prostate Cancer
  • +3 more
  • Ann Arbor, Michigan
  • +3 more
Feb 2, 2023

Growth Hormone Disorder, Growth Hormone Deficiency in Children Trial in Worldwide (somapacitan, Norditropin® FlexPro® pen)

Recruiting
  • Growth Hormone Disorder
  • Growth Hormone Deficiency in Children
  • San Diego, California
  • +55 more
Mar 18, 2022

HR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients Trial (PERT-IJS plus trastuzumab,

Not yet recruiting
  • HR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients
  • PERT-IJS plus trastuzumab, carboplatin and docetaxel
  • Perjeta plus trastuzumab, carboplatin and docetaxel
  • (no location specified)
Sep 21, 2023

Prostatic Tumors Trial in Japan (Androgen-deprivation Therapy (ADT), Bicalutamide, Abiraterone)

Active, not recruiting
  • Prostatic Neoplasms
  • Androgen-deprivation Therapy (ADT)
  • +6 more
  • Akita, Japan
  • +76 more
Jan 19, 2023

Growth Hormone-Deficiency Trial in Worldwide (TV-1106, somatropin)

Terminated
  • Growth Hormone-Deficiency
  • Minsk, Belarus
  • +33 more
Nov 5, 2021

Metastatic Prostate Cancer Trial in Worldwide (drug, radiation, other)

Active, not recruiting
  • Metastatic Prostate Cancer
  • abiraterone acetate
  • +3 more
  • Aalst, Belgium
  • +76 more
Sep 28, 2021

Growth Hormone Deficiency Trial in Worldwide (LUM-201, rhGH Norditropin® pen (34 µg/kg))

Recruiting
  • Growth Hormone Deficiency
  • LUM-201
  • rhGH Norditropin® pen (34 µg/kg)
  • Birmingham, Alabama
  • +52 more
Jan 30, 2023

Prostatic Tumors Trial in Bronx (Abiraterone Acetate, Prednisone)

Active, not recruiting
  • Prostatic Neoplasms
  • Bronx, New York
    Montefiore Medical Center
Sep 22, 2022

Taking Daily Growth Hormone Injections to Weekly Ngenla in Low

Not yet recruiting
  • Pediatric Growth Hormone Deficiency
  • Sharps bin to collect used needles/injections
  • (no location specified)
Nov 1, 2023

Hormone Naïve Prostate Cancer and Without Comorbidities Treated

Completed
  • Advanced Prostate Cancer
  • Degarelix
  • LHRH agonist (Leuprorelinacetat, Goserelinacetat, Buserelinacetat, Triptorelinacetat)
  • Rottweil, Germany
    Investigational site (there may be other sites in this country)
Jul 1, 2019

Non-metastatic, Hormone naïve Prostate Cancer Trial in New York, Durham (Enzalutamide, Androgen deprivation therapy, Supervised

Completed
Has Results
  • Non-metastatic, Hormone naïve Prostate Cancer
  • New York, New York
  • +1 more
Mar 28, 2019

Prostate Cancer, Bone Metastases Trial in Brescia (Zoledronic Acid, Enzalutamide)

Recruiting
  • Prostate Cancer
  • Bone Metastases
  • Brescia, Italy
    Azienda Ospedaliera Spedali Civili di Brescia
Mar 4, 2022

Liquid Biopsy Genomic Profiling on Treatment Metastatic Prostate

Recruiting
  • Metastatic Prostate Cancer
  • Liquid Biopsy
  • Archival Tumor DNA sequencing
  • Barcelona, Spain
    SOLTI Cancer Research Group
May 22, 2023

Prostate Cancer, Prostate Adenocarcinoma Trial in Charlotte (ADT+Docetaxel+Enzalutamide)

Active, not recruiting
  • Prostate Cancer
  • Prostate Adenocarcinoma
  • Charlotte, North Carolina
    Levine Cancer Institute
Jan 12, 2023

Healthly Volunteers Trial in Baltimore (Norditropin, Placebo)

Completed
  • Healthly Volunteers
  • Baltimore, Maryland
    National Institute of Aging, Clinical Research Unit
Aug 24, 2022

Growth Disorders, Growth Failure, Growth Hormone Treatment Trial in New York (Somatropin)

Recruiting
  • Growth Disorders
  • +3 more
  • New York, New York
    Northwell Health
Oct 26, 2023